Katherine MacLean, PhD is a research psychologist with expertise in studying the effects of mindfulness meditation and psychedelics on cognitive performance, emotional well-being, spirituality, and brain function. As a postdoctoral research fellow and faculty member at the Johns Hopkins University School of Medicine, she conducted clinical trials of psilocybin, the primary chemical found in "magic mushrooms", and other psychedelic compounds. Her ground-breaking research on psilocybin and personality change suggests that psychedelic medicines can enhance openness to new experiences, promote mental health and emotional well-being, and improve creativity throughout the lifespan. Dr. MacLean is the co-founder and current director of the Psychedelic Education and Continuing Care Program in New York, where she leads training workshops, educational seminars, and monthly integration groups focused on increasing awareness and reducing risks of psychedelic use. Email: firstname.lastname@example.org
Ingmar Gorman, Ph.D., is a clinical psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Administrative Director of the Psychedelic Education and Continuing Care Program, where he leads groups, trainings, and works with individual clients. Dr. Gorman is also site Co-principal Investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder. He is a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. Email: email@example.com
Andrew Tatarsky, Ph.D., is a leader in the field of harm reduction psychotherapy. The founder and director of The Center for Optimal Living in New York City, where treatment and professional training is based on Integrative Harm Reduction Therapy (IHRP). He has specialized in the field of substance use treatment for 35 years working as a counselor, psychologist, program director, trainer, advocate and author. He has devoted his career to developing a comprehensive understanding of the broad spectrum of substance use problems and an integrative harm reduction psychotherapy approach to treating this spectrum.
Jen Talley, Ph.D. is a clinical psychologist who specializes in the treatment of trauma and co-occurring substance misuse. She is the Assistant Director of The Center for Optimal Living. Working from an integrative harm reduction framework, Dr. Talley’s approach is interactive and focuses on the development of practical skills to manage intense emotions, reduce self-judgment, and promote self-compassion. Mindfulness skills are integrated into an active exploration of the interrelationship between thoughts, feelings, physical sensations, and behaviors, along with their contribution to substance misuse and relationship issues. Dr. Talley is also the Assistant Director of the Concentration in Mental Health and Substance Abuse Counseling at the New School for Social Research where she participates in the training and supervision of graduate students in psychology.